BRIDGEBIO PHARMA AGREES WITH U.S.

GOVERNMENT TO EXPAND MEDICAID AND MEDICARE PART D ACCESS TO ATTRUBY, WITHOUT FUTURE PRICING MANDATES.

متن اصلی؛ ترجمهٔ فارسی ندارد